The support you need to succeed on PEGASYS® (Peginterferon alfa-2a) therapy

What Is "Successful" Treatment?

The goals of treatment are to significantly reduce or eliminate the virus in your blood (virologic response) and reduce inflammation in the liver (histologic response).

There are three main ways doctors evaluate your treatment:

  • Virologic Response: how much hepatitis C virus is in your blood? This is known as your "viral load." It's the most common way to evaluate hepatitis C treatment. The best result would be a "sustained virologic response," which simply means that the virus is still undetectable in your blood 6 months or more after you complete treatment. In studies that followed patients for up to 5 years after their sustained virologic response, fewer than 1% had a recurrence of HCV infection
  • Histologic Response: has your liver inflammation gone down? Therapy may help your liver by reducing inflammation
  • Liver Enzymes: do you have high levels of ALT in your blood? An increase in a liver enzyme called alanine aminotransferase (ALT) indicates liver damage. However, 40% of people with chronic hepatitis C do not have elevated ALT levels. And your ALT level alone is not sufficient to determine the progression of your condition

Combination therapy with pegylated interferon and ribavirin can render the virus undetectable in up to 5 out of 10 patients with genotype 1, and in up to 8 out of 10 persons with genotypes 2 and 3.

Continue to learn the duration of treatment

Learn about PEGASYS Therapy

Find out how PEGASYS fights the hepatitis C virus and what you can expect from therapy.

Click here

24/7 Nurse Support

Need help with your injections or knowledgeable advice about side effects?

Call 1-877-734-2797 anytime.
For U.S. Patients Only